相似文献
1
Treatments for COVID-19: emerging drugs against the coronavirus - reply.
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.10108.
2
Treatments for COVID-19: emerging drugs against the coronavirus.
Acta Biomed. 2020 Jun 30;91(3):ahead of print. doi: 10.23750/abm.v91i3.9982.
3
Reply Letter - COVID-19 (Novel Coronavirus 2019) - Recent trends.
Eur Rev Med Pharmacol Sci. 2020 Jun;24(12):6482-6483. doi: 10.26355/eurrev_202006_21629.
4
Reply to "Coronavirus Disease 19 (COVID-19): Implications for Clinical Dental Care".
J Endod. 2020 Sep;46(9):1342. doi: 10.1016/j.joen.2020.08.005. Epub 2020 Aug 15.
5
Reply to "Opening Up Resident Education During the Coronavirus Disease (COVID-19) Pandemic and Beyond".
AJR Am J Roentgenol. 2020 Oct;215(4):W49. doi: 10.2214/AJR.20.23881. Epub 2020 Jul 29.
6
Reply to "On the Role of Chest Radiography and CT in the Coronavirus Disease (COVID-19) Pandemic".
AJR Am J Roentgenol. 2020 Oct;215(4):W45. doi: 10.2214/AJR.20.24159. Epub 2020 Jul 22.
7
In Reply to the Letter to the Editor Regarding "Neurological Impact of Coronavirus Disease (COVID-19): Practical Considerations for the Neuroscience Community".
World Neurosurg. 2020 Oct;142:535-536. doi: 10.1016/j.wneu.2020.06.115. Epub 2020 Jun 23.
8
Pediatric Coronavirus Disease-19 (COVID-19): Meta-analyzing Literature Versus Natural History: Authors' Reply.
Indian Pediatr. 2020 Sep 15;57(9):870. doi: 10.1007/s13312-020-1978-4.
9
Reply to "Critical Review of the Literature on Chest CT and Coronavirus Disease (COVID-19): Data Adjustment".
AJR Am J Roentgenol. 2020 Aug;215(2):W28. doi: 10.2214/AJR.20.23564. Epub 2020 Jun 1.
10
Coronavirus Disease 2019 (COVID-19): Emerging and Future Challenges for Dental and Oral Medicine.
J Dent Res. 2020 Aug;99(9):1113. doi: 10.1177/0022034520932149. Epub 2020 May 28.
本文引用的文献
1
Treatments for COVID-19: emerging drugs against the coronavirus.
Acta Biomed. 2020 May 11;91(2):118-136. doi: 10.23750/abm.v91i2.9639.
2
First-line drugs for hypertension.
Cochrane Database Syst Rev. 2018 Apr 18;4(4):CD001841. doi: 10.1002/14651858.CD001841.pub3.
3
Blood pressure-lowering efficacy of reserpine for primary hypertension.
Cochrane Database Syst Rev. 2016 Dec 21;12(12):CD007655. doi: 10.1002/14651858.CD007655.pub3.
4
A Kinome-Wide Small Interfering RNA Screen Identifies Proviral and Antiviral Host Factors in Severe Acute Respiratory Syndrome Coronavirus Replication, Including Double-Stranded RNA-Activated Protein Kinase and Early Secretory Pathway Proteins.
J Virol. 2015 Aug;89(16):8318-33. doi: 10.1128/JVI.01029-15. Epub 2015 Jun 3.
5
Molecular interactions in the assembly of coronaviruses.
Adv Virus Res. 2005;64:165-230. doi: 10.1016/S0065-3527(05)64006-7.
6
Small molecules targeting severe acute respiratory syndrome human coronavirus.
Proc Natl Acad Sci U S A. 2004 Jul 6;101(27):10012-7. doi: 10.1073/pnas.0403596101. Epub 2004 Jun 28.
7
Aspects of tolerability of centrally acting antihypertensive drugs.
J Cardiovasc Pharmacol. 1996;27 Suppl 3:S49-54. doi: 10.1097/00005344-199627003-00007.
Zotero 插件